CSF measurements of Aβ42, tau, and ptau181 were available for 479 participants (67 HC, 209 preclinical AD, 93 MCI due to AD, and 110 dementia due to AD), of whom 60 had ARHL (Table 1). The gene discussed is MAPT; the disease is Alzheimer disease.